고등급 방광요관역류에서 변형된 내시경적 주입술기의 효용성 = Efficacy of the Modified STING Procedure for the Treatment of High Grade Vesicoureteral Reflux

다국어 초록 (Multilingual Abstract)

Purpose: The modified subureteral transurethral injection(STING) has been reported to increase the success of endoscopic treatment of high grade vesicoureteral reflux(VUR). This study was performed to assess the efficacy of the modified STING procedure compared to conventional STING in the setting of high grade VUR.
Materials and Methods: We retrospectively reviewed the medical records of 40 consecutive children(46 ureters) with a median age of 5.32 years (range 1 to 10 years) who underwent endoscopic treatment of grade IV to grade V VUR between February 2004 and December 2006. The modified STING was performed by applying a direct pressure stream of irrigation fluid into the ureter in order to define the injection site within the ureteral submucosa. The needle was then placed in the ureteral tunnel, and a dextranomer/hyaluronic acid copolymer(Dx/HA) was injected into the submucosal intraureteral space, tracking along the entire length of the detrusor tunnel. Modified STING was performed in 27 ureters(grade IV: 13, grade V: 14), and conventional STING was performed in 19 ureters (grade IV: 12, grade V: 7). Follow-up voiding cystourethrography(VCUG) was performed 3 months later.
Results: Complete resolution occurred in 82%(22/27 ureters) of the patients undergoing modified STING, including 92%(12/13) of grade IV patients and 71%(10/14) of grade V patients. Three ureters required a second injection to correct VUR. Conventional STING had a success rate of 63%(12/19), [75%(9/12) in grade IV and 43%(3/7) in grade V]. The mean injected volume for the modified STING was 1.23±0.3ml, while that for the conventional STING was 0.95±0.2ml(p=0.03).
Conclusions: The modified STING was markedly more successful in the treatment of high grade VUR and carried no significant adverse effects.

다국어 초록 (Multilingual Abstract)

Purpose: The modified subureteral transurethral injection(STING) has been reported to increase the success of endoscopic treatment of high grade vesicoureteral reflux(VUR). This study was performed to assess the efficacy of the modified STING procedure compared to conventional STING in the setting of high grade VUR.
Materials and Methods: We retrospectively reviewed the medical records of 40 consecutive children(46 ureters) with a median age of 5.32 years (range 1 to 10 years) who underwent endoscopic treatment of grade IV to grade V VUR between February 2004 and December 2006. The modified STING was performed by applying a direct pressure stream of irrigation fluid into the ureter in order to define the injection site within the ureteral submucosa. The needle was then placed in the ureteral tunnel, and a dextranomer/hyaluronic acid copolymer(Dx/HA) was injected into the submucosal intraureteral space, tracking along the entire length of the detrusor tunnel. Modified STING was performed in 27 ureters(grade IV: 13, grade V: 14), and conventional STING was performed in 19 ureters (grade IV: 12, grade V: 7). Follow-up voiding cystourethrography(VCUG) was performed 3 months later.
Results: Complete resolution occurred in 82%(22/27 ureters) of the patients undergoing modified STING, including 92%(12/13) of grade IV patients and 71%(10/14) of grade V patients. Three ureters required a second injection to correct VUR. Conventional STING had a success rate of 63%(12/19), [75%(9/12) in grade IV and 43%(3/7) in grade V]. The mean injected volume for the modified STING was 1.23±0.3ml, while that for the conventional STING was 0.95±0.2ml(p=0.03).
Conclusions: The modified STING was markedly more successful in the treatment of high grade VUR and carried no significant adverse effects.

참고문헌 (Reference)

• 1 김현철, "방광요관 역류에서 요관하 Polydimethylsiloxane 주입술의 초기경험과 기술적 측면" 대한비뇨기과학회 47 (47): 154-159, 2006
• 2 Higham-Kessler, "review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer microspheres" 177 : 710-4, 2007
• 3 O'Donnell B, "Treatment of vesicoureteric reflux by endoscopic injection of Teflon" 289 : 7-9, 1984
• 4 Matouschek E, "Treatment of vesicorenal reflux by transurethral teflon-injection(author's transl)" 20 : 263-4, 1981
• 5 Capozza N, "Treatment of vesico-ureteric reflux: a new algorithm based on parental preference" 92 : 285-8, 2003
• 6 Capozza N, "The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience" 172 : 1626-8, 2004
• 7 Kirsch AJ, "The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter" 171 : 2413-6, 2004
• 8 Puri P, "Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux" 176 : 1856-9, 2006
• 9 Schwab CW Jr, "Spontaneous resolution of vesicoureteral reflux: a 15-year perspective" 168 : 2594-9, 2002
• 10 Elder JS, "Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children" 157 : 1846-51, 1997
• 11 Koyle MA, "Part 4: considerations regarding the medical management of VUR: What have we really learned?" 23(Suppl 4) : S21-5, 2007
• 12 Diamond DA, "Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy" 170 : 1556-8, 2003
• 13 Lebowitz RL, "International system of radiographic grading of vesicoureteric reflux. International reflux study in children" 15 : 105-9, 1985
• 14 Dawrant MJ, "Endoscopic treatment for high grade vesicoureteral reflux in infants" 176 : 1847-50, 2006
• 15 Capozza N, "Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis" 140 : 230-4, 2002
• 16 Puri P, "Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon" 289 : 5-7, 1984